Study of effects of modafinil add-on therapy on excessive day time drowsiness and weight gain in patients on atypical antipsychotics (original) (raw)

A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia

John Vijay Sagar Kommu

Indian Journal of Psychological Medicine, 2014

View PDFchevron_right

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review

Anna Yusim

Journal of Clinical Psychiatry, 2008

View PDFchevron_right

Modafinil as an Adjunctive Treatment of Sedation, Negative Symptoms, and Cognition in Schizophrenia

Deepti Anbarasan

The Journal of Clinical Psychiatry, 2009

View PDFchevron_right

Metabolic Disturbances Associated With Atypical Antipsychotics

Michel Bourin

2018

View PDFchevron_right

Modafinil-Associated Weight Loss in a Clozapine-Treated Schizoaffective Disorder Patient

Leah Briggs

Annals of Clinical Psychiatry, 2005

View PDFchevron_right

Antipsychotic treatment--side-effect and/or metabolic syndrome

Tija Palijan

Psychiatria Danubina, 2011

View PDFchevron_right

The Effectiveness of Augmenting Modafinil to Risperidone or Olanzapine for Treating Negative Symptoms in Schizophrenic Patients

hatam boostani

Murāqibat-i bīmārī/hā-yi muzmin-i Jundī/shāpūr, 2024

View PDFchevron_right

The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity

Andrzej Kiejna

European Journal of Clinical Nutrition, 2014

View PDFchevron_right

Conventional and Atypical Antipsychotics

Mowadat Rana

The Professional Medical Journal

View PDFchevron_right

Clinical pharmacology of atypical antipsychotics: an update

Massimo Carlo Mauri

EXCLI journal, 2014

View PDFchevron_right

Metabolic side effects of antipsychotic agents: a prospective study in a teaching hospital

Varsha Patel

View PDFchevron_right

Review article: CLINICAL PHARMACOLOGY OF ATYPICAL ANTIPSYCHOTICS: AN UPDATE

Filippo Dragogna

2014

View PDFchevron_right

Modafinil-Induced Psychosis: A Case Report

Hayriye Yalvaç

Noro psikiyatri arsivi, 2015

View PDFchevron_right

Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms

Gavin Reynolds

Pharmacology & therapeutics, 2010

View PDFchevron_right

Adverse metabolic effects following the use of atypical antipsychotics

Christos Theleritis

View PDFchevron_right

Second-Generation (Atypical) Antipsychotics and Metabolic Effects

John Newcomer

CNS Drugs, 2005

View PDFchevron_right

Reduction of daytime sleepiness in a depressive patient during adjunct treatment with modafinil

Serge Brand

European Neuropsychopharmacology, 2001

View PDFchevron_right

Belgian consensus on metabolic problems associated with atypical antipsychotics

L. Van Gaal

International Journal of Psychiatry in Clinical Practice, 2005

View PDFchevron_right

An Evaluation of Efficacy and Safety of Antipsychotic Medications in Patients Suffering from Psychiatric Illness

Anuradha Gandhi

2013

View PDFchevron_right

Three Case Reports of Modafinil Use in Treating Sedation Induced by Antipsychotic Medications

William Cutlip

The Journal of Clinical Psychiatry, 2003

View PDFchevron_right

Experience with the use of modafinil in the treatment of narcolepsy in a outpatient facility specialized in diurnal excessive sleepiness in São Paulo

Daniel Rodrigues Pereira

Sleep Science, 2014

View PDFchevron_right

Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain

Linda Scoriels

View PDFchevron_right

Metabolic and Cardiovascular Adverse Effects Associated with Treatment with Antipsychotic Drugs

Marc Hert

Journal of Experimental & Clinical Medicine, 2012

View PDFchevron_right

Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants

John Harsh

Sleep Medicine, 2003

View PDFchevron_right

Antipsychotic agents: efficacy and safety in schizophrenia

Mario F Juruena, Eduardo Ponde de Sena

Drug, healthcare and patient safety, 2012

View PDFchevron_right

Conference report: Belgian consensus on metabolic problems associated with second-generation antipsychotics

L. Van Gaal

International Journal of Psychiatry in Clinical Practice

View PDFchevron_right

Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects

Yiwei Ng

Mental Health Clinician, 2016

View PDFchevron_right

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

Wendell Grogan

Neurology, 2000

View PDFchevron_right